Trouble ahead: Obese, diabetic 50 somethings heading
It’s not too late It’s not too late Today’s middle-aged adults (50-64)
Biosimilars are “me-too” drugs, not generics
Time to take off the blinders Time to take off the blinders Generic drugs
Surgeons and truck drivers may soon have
Climbing into the future Climbing into the future Many Americans feel economically insecure. Donald
Good riddance: United finally gives up on
United we hardly knew ye United we hardly knew ye United Healthcare announced that
Is pharma industry too meek on pricing?
What were we thinking? What were we thinking? The biopharmaceutical industry has been under
Should Medicare negotiate drug prices? Probably not
A popular idea, but not a good one. A popular idea, but not a
In Medicare Advantage, providers are becoming payers
Payer, provider or PayVider? Payer, provider or PayVider? Accountable Care Organizations enable providers of
Like I said: United’s ACA exchange departure
Robert Wood Johnson Foundation funded an Urban Institute study to determine how Obamacare marketplaces
Is Generally Regarded as Safe (GRAS) safe
What did I eat? What did I eat? Unlike most people exposed to the Frontline investigation of